Incidence and treatment outcomes of pharyngeal neisseria gonorrhoeae and chlamydia trachomatis infections in men who have sex with men: A 13-Year retrospective cohort study

Clinical Infectious Diseases

Volumn 48, Issue 9, 2009, Pages 1237-1243

  Ota, Kaede V ^a,b   Fisman, David N ^a,b,c   Tamari, Itamar E ^d   Smieja, Marek ^e   Ng, Lai King ^f   Jones, Karen E ^b   Diprima, Alessandro ^c   Richardson, Susan E ^a,b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ONTARIO MINISTRY OF HEALTH AND LONG TERM CARE   (Canada)

^d Hassle Free Men's Clinic   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

^f PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; OFLOXACIN; PENICILLIN G; SPECTINOMYCIN; TETRACYCLINE; ANTIINFECTIVE AGENT; BACTERIAL DNA;

ABSTINENCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COHORT ANALYSIS; GONOCOCCAL URETHRITIS; GONORRHEA; HUMAN; INCIDENCE; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MEDICAL DOCUMENTATION; MEDICAL RECORD; NEISSERIA GONORRHOEAE; PHARYNGITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEQUENCE ANALYSIS; SINGLE DRUG DOSE; TREATMENT OUTCOME; URETHRA; URINALYSIS; BACTERIUM IDENTIFICATION; CANADA; DNA FINGERPRINTING; DRUG EFFECT; GENETICS; GENOTYPE; HOMOSEXUALITY; ISOLATION AND PURIFICATION; MICROBIOLOGY; PHARYNX DISEASE; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CANADA; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COHORT STUDIES; DNA FINGERPRINTING; DNA, BACTERIAL; GENOTYPE; GONORRHEA; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; NEISSERIA GONORRHOEAE; PHARYNGEAL DISEASES; RETROSPECTIVE STUDIES; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 65549091904     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/597586     Document Type: Article

References (23)

1. Centers for Disease Control and Prevention. Increases in unsafe sex and rectal gonorrhea among men who have sex with men-San Francisco, 1994-1997. MMWR Morb Mortal Wkly Rep 1999; 48:45-8.
2. Kent CK, Chaw JK, Wong W, et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis 2005;41:67-74.
3. Lafferty WE, Hughes JP, Handsfield HH. Sexually transmitted diseases in men who have sex with men: acquisition of gonorrhea and nongonococcal urethritis by fellatio and implications for STD/HIV prevention. Sex Transm Dis 1997; 24:272-8.
4. Morris SR, Klausner JD, Buchbinder SP, et al. Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: the EXPLORE study. Clin Infect Dis 2006;43:1284-9.
5. Ota K, Tamari I, Smieja M, et al. Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in pharyngeal and rectal specimens using the BD ProbeTec ET system, the Gen-Probe APTIMA Combo 2 assay and culture. Sex Transm Infect 2009 (Epub ahead of print).
6. Diggle P. Spectral Analysis. In: Time series, a biostatistical introduction. Oxford, England: Oxford University Press, 1989:94-133.
7. NG-MAST. Neisseria gonorrhoeae multi antigen sequence typing. Available at: http://www.ng-mast.net/misc/info.asp. Accessed 2 October 2008.
8. Schachter J, Moncada J, Liska S, Shayevich C, Klausner JD. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis 2008; 35:637-42.
9. Jebakumar SPR, Storey C, Lusher M, Nelson J, Goorney B, Haye KR. Value of screening for oropharyngeal Chlamydia trachomatis infection. J Clin Pathol 1995;48:658-61.
10. Coughlan E, Young S. Screening for pharyngeal Chlamydia trachomatis in asymptomatic men who have sex with men. N Z Med J 2006; 119: U1948.
11. McMillan A, Sommerville RG, McKie PMK. Chlamydia infection in homosexual men: frequency of isolation of Chlamydia trachomatis from the urethra, ano-rectum, and pharynx. Br J Vener Dis 1981;57:47-9.
12. Jones RB, Rabinovitch RA, Katz BP, et al. Chlamydia trachomatis in the pharynx and rectum of heterosexual patients at risk for genital infection. Ann Intern Med 1985; 102:757-62.
13. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR Morb Mortal Wkly Rep 2006;55:1-94.
14. Public Health Agency of Canada. Canadian Guidelines on Sexually Transmitted Infections, 2006 edition. Ottawa, Canada: Public Health Agency of Canada, 2006.
15. Page-Shafer K, Graves A, Kent C, et al. Increased sensitivity of DNA amplification testing for the detection of pharyngeal gonorrhea in men who have sex with men. Clin Infect Dis 2002; 34:173-6.
16. McMillan A, Young H. The treatment of pharyngeal gonorrhoea with a single oral dose of cefixime. Int J STD AIDS 2007; 18:253-4.
17. Sathia L, Ellis B, Phillip S, Winston A, Smith A. Pharyngeal gonor-rhoea-is dual therapy the way forward? Int J STD AIDS 2007;18: 647-54.
18. Mikamo H. Ninomiya M. Tamaya T. Clinical efficacy of clarithromycin against uterine cervical and pharyngeal Chlamydia trachomatis and the sensitivity of polymerase chain reaction to detect C. trachomatis at various time points after treatment. J Infect Chemother 2003; 9:282-3.
19. Manavi K, Young H, McMillan A. The outcome of oropharyngeal gonorrhoea treatment with different regimens. Int J STD AIDS 2005; 16:68-70.
20. Vogels WH, van Voorst Vader PC, Schroder FP. Chlamydia trachomatis infection in a high-risk population: comparison of polymerase chain reaction and cell culture for diagnosis and follow-up. J Clin Microbiol 1993;31:1103-7.
21. Hansfield HH, McCormack WM, Hook EW 3rd, et al.; The Gonorrhoea Treatment Study Group. A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhoea. N Engl JMed 1991; 325:1337-41.
22. Portilla I, Lutz B, Montalvo M, Mogabgab WJ. Oral cefixime versus intramuscular ceftriaxone in patients with uncomplicated gonococcal infections. Sex Transm Dis 1992; 19:94-8.
23. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chla- mydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis 2002; 29:497-502.